Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mesa Laboratories, Inc. - Common Stock (NQ: MLAB )

145.90 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20
Open 145.90
Bid (Size) 59.11 (1)
Ask (Size) 233.44 (2)
Prev. Close 145.90
Today's Range 145.90 - 145.90
52wk Range 83.68 - 155.12
Shares Outstanding 5,384,291
Dividend Yield 0.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies. 
Via Benzinga
Recap: Mesa Laboratories Q3 Earnings
Via Benzinga

Performance

YTD
+10.56%
+10.56%
1 Month
-0.50%
-0.50%
3 Month
+44.66%
+44.66%
6 Month
+13.19%
+13.19%
1 Year
+42.11%
+42.11%

More News

Read More
Earnings Preview: Mesa Laboratories
Via Benzinga
Evercore ISI Group Upgrades Mesa Laboratories: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 4, 2025
Via Benzinga
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
Earnings Scheduled For November 6, 2023
Via Benzinga
MLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024
Via InvestorPlace
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Labs Releases Second Annual Responsible Business Program Brochure
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Laboratories Appoints Mark Capone to its Board of Directors
From Mesa Laboratories, Inc.
Via GlobeNewswire
Earnings Scheduled For February 5, 2024
Via Benzinga
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
From Mesa Laboratories, Inc.
Via GlobeNewswire
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
From Mesa Laboratories, Inc.
Via GlobeNewswire
MESA LABS DECLARES QUARTERLY DIVIDEND
From Mesa Laboratories, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.